Lanean...
Clinical and Immunological Outcome in Cutaneous Leishmaniasis Patients Treated with Pentoxifylline
Pentoxifylline is a tumor necrosis factor-α (TNF-α) inhibitor that also attenuates the immune response and decreases tissue inflammation. The association of pentoxifylline with antimony improves the cure rate of mucosal and cutaneous leishmaniasis. In this randomized and double blind pilot trial, cu...
Gorde:
| Egile Nagusiak: | , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The American Society of Tropical Medicine and Hygiene
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3973503/ https://ncbi.nlm.nih.gov/pubmed/24567316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.12-0729 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|